Literature DB >> 7704562

Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias.

G Monti1, M Galli, F Invernizzi, P Pioltelli, F Saccardo, A Monteverde, M Pietrogrande, P Renoldi, S Bombardieri, G Bordin.   

Abstract

In a multi-centre retrospective study, we compared clinical and laboratory data in 913 patients with cryoglobulinaemias, divided as: (i) essential cryoglobulinaemias; (ii) cryoglobulinaemias secondary to connective tissue diseases (CTD), lymphoproliferative or other haematological diseases (LPD), chronic liver diseases (CLD), and 'other diseases'. Purpura was the commonest presenting feature in all groups and was more common in essential cryoglobulinaemias (p < 0.0001). Meltzer's triad (purpura, arthralgia, weakness) was less frequent, but similarly distributed. Renal involvement was randomly distributed. Neurological impairment was less frequent in cryoglobulinaemias secondary to CLD (p < 0.002). Raynaud's phenomenon, arthritis and sicca syndrome were more frequent in cryoglobulinaemias secondary to CTD. Essential cryoglobulinaemias had a significantly higher percentage of serum complement C4 < 8 mg/dl (p < 0.004), of detectable rheumatoid factor activity (p < 0.0002), and of type II cryoglobulins (p < 0.0001). Liver involvement was evident at presentation in 32.6% of essential cryoglobulinaemias, 27.1% of cryoglobulinaemias secondary to LPD and 12.2% of cryoglobulinaemias secondary to CTD. Antibodies to hepatitis B surface (HBsAg) and core (HBc) antigens were more frequent in cryoglobulinaemias secondary to CLD; anti-HBs antibodies were randomly distributed. Antibodies to hepatitis C (HCV) were tested for in 224 patients, and prevalence was high in all the groups, but lower in cryoglobulinaemias secondary to CTD (p < 0.0001). Type II and type III essential cryoglobulinaemias differed significantly in renal involvement (p < 0.0001), cryocrit > 3% (p < 0.0001), C4 < 15 mg/dl (p < 0.001), HBsAg prevalence (p < 0.01) and purpura (p < 0.05). Despite the high prevalence of HCV markers in all groups, the role of HCV in essential cryoglobulinaemia is not well defined; HBV seems to play only a marginal role.

Entities:  

Mesh:

Year:  1995        PMID: 7704562

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  45 in total

1.  Mixed cryoglobulinaemia after hepatitis C virus: more and less ambiguity.

Authors:  V Agnello
Journal:  Ann Rheum Dis       Date:  1998-12       Impact factor: 19.103

2.  A 59 year old man with progressive spinal cord and peripheral nerve dysfunction culminating in encephalopathy: Edinburgh advanced clinical neurology course, 1999.

Authors:  R Al-Shahi; C P Warlow; G H Jansen; C J Frijns; J van Gijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

3.  Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.

Authors:  Mohamad Zaidan; Benjamin Terrier; Agnieszka Pozdzik; Thierry Frouget; Nathalie Rioux-Leclercq; Christian Combe; Sébastien Lepreux; Aurélie Hummel; Laure-Hélène Noël; Isabelle Marie; Bruno Legallicier; Arnaud François; Antoine Huart; David Launay; Gilles Kaplanski; Frank Bridoux; Philippe Vanhille; Raifah Makdassi; Jean-François Augusto; Philippe Rouvier; Alexandre Karras; Chantal Jouanneau; Marie-Christine Verpont; Patrice Callard; Fabrice Carrat; Olivier Hermine; Jean-Marc Léger; Xavier Mariette; Patricia Senet; David Saadoun; Pierre Ronco; Isabelle Brochériou; Patrice Cacoub; Emmanuelle Plaisier
Journal:  J Am Soc Nephrol       Date:  2015-08-10       Impact factor: 10.121

Review 4.  Management of patients with hepatitis C infection and renal disease.

Authors:  Chalermrat Bunchorntavakul; Monthira Maneerattanaporn; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2015-02-27

Review 5.  Kidney transplantation from donors with hepatitis C infection.

Authors:  Massimiliano Veroux; Daniela Corona; Nunziata Sinagra; Alessia Giaquinta; Domenico Zerbo; Burcin Ekser; Giuseppe Giuffrida; Pietro Caglià; Riccardo Gula; Vincenzo Ardita; Pierfrancesco Veroux
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

6.  Cryoglobulins are not essential.

Authors:  M Trendelenburg; J A Schifferli
Journal:  Ann Rheum Dis       Date:  1998-01       Impact factor: 19.103

Review 7.  Hepatitis C virus syndrome: A constellation of organ- and non-organ specific autoimmune disorders, B-cell non-Hodgkin's lymphoma, and cancer.

Authors:  Clodoveo Ferri; Marco Sebastiani; Dilia Giuggioli; Michele Colaci; Poupak Fallahi; Alessia Piluso; Alessandro Antonelli; Anna Linda Zignego
Journal:  World J Hepatol       Date:  2015-03-27

Review 8.  Cryoglobulins.

Authors:  C Ferri; A L Zignego; S A Pileri
Journal:  J Clin Pathol       Date:  2002-01       Impact factor: 3.411

Review 9.  [Renal manifestations of rheumatic diseases].

Authors:  A Schwarting; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

Review 10.  Complement and autoimmunity.

Authors:  Eleonora Ballanti; Carlo Perricone; Elisabetta Greco; Marta Ballanti; Gioia Di Muzio; Maria Sole Chimenti; Roberto Perricone
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.